560 related articles for article (PubMed ID: 35119030)
1. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
Dai Y; Guo M; Jiang L; Gao J
Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
[TBL] [Abstract][Full Text] [Related]
2. Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.
Guo MF; Dai YJ; Gao JR; Chen PJ
J Diabetes Res; 2020; 2020():5947304. PubMed ID: 32215271
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
[TBL] [Abstract][Full Text] [Related]
4. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
[TBL] [Abstract][Full Text] [Related]
5. The Mechanism of Plantaginis Semen in the Treatment of Diabetic Nephropathy based on Network Pharmacology and Molecular Docking Technology.
He L; Shen K; He L; Chen Y; Tang Z
Endocr Metab Immune Disord Drug Targets; 2024; 24(3):363-379. PubMed ID: 37718520
[TBL] [Abstract][Full Text] [Related]
6. Based on network pharmacology and bioinformatics to analyze the mechanism of action of Astragalus membranaceus in the treatment of vitiligo and COVID-19.
Wang Y; Ding M; Chi J; Wang T; Zhang Y; Li Z; Li Q
Sci Rep; 2023 Mar; 13(1):3884. PubMed ID: 36890149
[TBL] [Abstract][Full Text] [Related]
7. Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy.
Dong Y; Zhao Q; Wang Y
Sci Rep; 2021 Sep; 11(1):19496. PubMed ID: 34593896
[TBL] [Abstract][Full Text] [Related]
8. Based on Network Pharmacology Tools to Investigate the Molecular Mechanism of Cordyceps sinensis on the Treatment of Diabetic Nephropathy.
Li Y; Wang L; Xu B; Zhao L; Li L; Xu K; Tang A; Zhou S; Song L; Zhang X; Zhan H
J Diabetes Res; 2021; 2021():8891093. PubMed ID: 33628839
[TBL] [Abstract][Full Text] [Related]
9. Integration of network pharmacology and molecular docking technology reveals the mechanism of the herbal pairing of Codonopsis Pilosula (Franch.) Nannf and Astragalus Membranaceus (Fisch.) Bge on chronic heart failure.
Xu J; Zhang Z; Zhou K; Li Y; Wan J; Mao T; Ji X; Liu J; Lin Q
Ann Palliat Med; 2021 Jul; 10(7):7942-7959. PubMed ID: 34353081
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
Guo M; Dai Y; Jiang L; Gao J
Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
[TBL] [Abstract][Full Text] [Related]
11. Exploring the target and molecular mechanism of Astragalus membranaceus in the treatment of vascular cognitive impairment based on network pharmacology and molecular docking.
Lin L; Chen W; Yao C; Wu L; Yan Q; Cai X; Zhu S; Lao Y; Zhang G; Lan X; Chen Y
Medicine (Baltimore); 2023 Mar; 102(12):e33063. PubMed ID: 36961195
[TBL] [Abstract][Full Text] [Related]
12. Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury.
Cao S; Hou G; Meng Y; Chen Y; Xie L; Shi B
Dis Markers; 2022; 2022():2141882. PubMed ID: 36157206
[TBL] [Abstract][Full Text] [Related]
13. Anticancer Effect of Active Component of Astragalus Membranaceus Combined with Olaparib on Ovarian Cancer Predicted by Network-Based Pharmacology.
Liu Y; Guo Z; Lang F; Li J; Jiang J
Appl Biochem Biotechnol; 2023 Nov; 195(11):6994-7020. PubMed ID: 36976504
[TBL] [Abstract][Full Text] [Related]
14. Exploring the role and mechanism of Astragalus membranaceus and radix paeoniae rubra in idiopathic pulmonary fibrosis through network pharmacology and experimental validation.
Jiang H; Zhou R; An L; Guo J; Hou X; Tang J; Wang F; Du Q
Sci Rep; 2023 Sep; 13(1):10110. PubMed ID: 37666859
[TBL] [Abstract][Full Text] [Related]
15. Exploring the mechanism of Dahuang-Tusizi drug pair in the treatment of diabetes nephropathy based on network pharmacology and immune infiltration analysis.
Liu W; Yuan L; Che M; Hou S; Meng F; Xu D; Nan Y
Medicine (Baltimore); 2023 Nov; 102(47):e36196. PubMed ID: 38013385
[TBL] [Abstract][Full Text] [Related]
16. Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.
Hu Y; Yu Y; Dong H; Jiang W
PeerJ; 2023; 11():e15437. PubMed ID: 37250717
[TBL] [Abstract][Full Text] [Related]
17. Exploring the action mechanism of Jinxin oral liquid on asthma by network pharmacology, molecular docking, and microRNA recognition.
Chen J; Zhu Q; Mo Y; Ling H; Wang Y; Xie H; Li L
Medicine (Baltimore); 2023 Oct; 102(43):e35438. PubMed ID: 37904411
[TBL] [Abstract][Full Text] [Related]
18. Identification of miRNAs-genes regulatory network in diabetic nephropathy based on bioinformatics analysis.
Yang F; Cui Z; Deng H; Wang Y; Chen Y; Li H; Yuan L
Medicine (Baltimore); 2019 Jul; 98(27):e16225. PubMed ID: 31277135
[TBL] [Abstract][Full Text] [Related]
19. Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy.
Fu S; Zhou Y; Hu C; Xu Z; Hou J
BMC Complement Med Ther; 2022 Aug; 22(1):210. PubMed ID: 35932042
[TBL] [Abstract][Full Text] [Related]
20. Uncovering the Key miRNAs and Targets of the Liuwei Dihuang Pill in Diabetic Nephropathy-Related Osteoporosis based on Weighted Gene Co-Expression Network and Network Pharmacology Analysis.
Liu MM; Lv NN; Geng R; Hua Z; Ma Y; Huang GC; Cheng J; Xu HY
Endocr Metab Immune Disord Drug Targets; 2022; 22(3):274-289. PubMed ID: 33588742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
